Next Article in Journal
Development and Validation of a Novel Serum Prognostic Marker for Patients with Metastatic Colorectal Cancer on Regorafenib Treatment
Next Article in Special Issue
Oncogenic KRAS: Signaling and Drug Resistance
Previous Article in Journal
Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands
Previous Article in Special Issue
KRAS G12C Mutations in NSCLC: From Target to Resistance
 
 
Review

Article Versions Notes

Cancers 2021, 13(20), 5081; https://doi.org/10.3390/cancers13205081
Action Date Notes Link
article pdf uploaded. 11 October 2021 15:59 CEST Version of Record https://www.mdpi.com/2072-6694/13/20/5081/pdf-vor
article xml file uploaded 12 October 2021 07:43 CEST Original file -
article xml uploaded. 12 October 2021 07:43 CEST Update https://www.mdpi.com/2072-6694/13/20/5081/xml
article pdf uploaded. 12 October 2021 07:43 CEST Updated version of record https://www.mdpi.com/2072-6694/13/20/5081/pdf
article html file updated 12 October 2021 07:46 CEST Original file -
article html file updated 12 October 2021 10:26 CEST Update -
article html file updated 30 July 2022 10:16 CEST Update https://www.mdpi.com/2072-6694/13/20/5081/html
Back to TopTop